Flume Health
We're Hiring!
Flume Health Company Growth, Stability & Outlook
What People Are Saying About Flume Health
-
Investor Backing & Capital Strength: Funding led by Optum Ventures with participation from Cigna Ventures in 2022 signals strong capitalization for continued product buildout; feedback suggests this has supported platform investment post‑pivot.
-
Product Line Growth: The launch of Flume Relay and ongoing platform development indicate expansion of the company’s integration capabilities; feedback suggests compliance milestones like HITRUST are enabling enterprise‑grade deployments.
-
Future-Ready Strategy: The 2023 pivot from TPA operations to a payer data/integration platform, coupled with HITRUST certification, points to preparation for larger payer integrations; feedback suggests the company is aligning to enterprise interoperability needs.
